非ホジキンスリンパ腫(Non-Hodgkin’s Lymphoma):疫学予測(~2023)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHCER061)
◆英語タイトル:EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2023
◆発行会社/調査会社:GlobalData
◆商品コード:GDHCER061
◆発行日:2014年5月5日
◆調査対象地域:グローバル
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD3,995 ⇒換算¥451,435見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD7,990 ⇒換算¥902,870見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD11,985 ⇒換算¥1,354,305見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[非ホジキンスリンパ腫(Non-Hodgkin’s Lymphoma):疫学予測(~2023)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

EpiCast Report: Non-Hodgkin’s Lymphoma – Epidemiology Forecast to 2023

Summary

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight infections and other diseases. NHL is characterized into three types – B-cell, T-cell, and natural killer lymphocyte lymphomas. B-cell lymphomas are the most common form of NHL in developed countries. NHL ranks as the most commonly occurring hematologic cancer in adults. Despite the many advances in research, NHL remains largely incurable and the causes unknown.

GlobalData epidemiologists forecast an increase in the incident cases of B-cell NHL in the 6MM, from 89,455 incident cases in 2013 to 111,366 incident cases in 2023, with an annual growth rate (AGR) of 2.45%. In 2023, the US will have the highest number of incident cases of B-cell NHL, with 56,033 incident cases, followed by Germany with 17,176 incident cases, and the UK with 12,548 incident cases.

For this analysis, GlobalData epidemiologists utilized peer-reviewed journals and country-specific disease databases to construct the 10-year epidemiological forecast for the incident cases of follicular lymphoma, marginal zone lymphoma, DLBCL, and mantle cell lymphoma in the 6MM. A major strength of GlobalData’s epidemiological analysis is the use of available country-specific sources, allowing for a meaningful comparison of the epidemiological characteristics of B-cell NHL in the 6MM. In addition, this forecast provides detailed segmentation of the B-cell NHL for each country by age, sex, and B-cell NHL subtype, thereby providing a comprehensive view of B-cell NHL in the 6MM.

Scope

- The Non-Hodgkin’s Lymphoma (NHL) EpiCast Report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for NHL in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast of the incident cases of follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma [DLBCL], and mantle cell lymphoma segmented by age (ages =30 years) and sex in these markets.
- The NHL epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global NHL market.
- Quantify patient populations in the global NHL market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for NHL therapeutics in each of the markets covered.

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 12
3.3.1 US 12
3.3.2 5EU 13
3.4 Forecast Methodology 16
3.4.1 Sources Used 18
3.4.2 Sources Not Used 20
3.4.3 Forecast Assumptions and Methods 21
3.4.4 Age-Standardized Incidence Rates 24
3.5 Epidemiological Forecast of B-Cell NHL (2013-2023) 25
3.5.1 Follicular Lymphoma 25
3.5.2 Marginal Zone Lymphoma 30
3.5.3 DLBCL 36
3.5.4 Mantle Cell Lymphoma 42
3.6 Discussion 48
3.6.1 Epidemiological Forecast Insight 48
3.6.2 Limitations of the Analysis 48
3.6.3 Strengths of the Analysis 49
4 Appendix 50
4.1 Bibliography 50
4.2 About the Authors 54
4.2.1 Epidemiologists 54
4.2.2 Reviewers 54
4.2.3 Global Director of Epidemiology 55
4.2.4 Global Head of Healthcare 56
4.3 About GlobalData 57
4.4 About EpiCast 57
4.5 Disclaimer 58

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for NHL 11
Table 2: US, Age- and Sex-Specific Incidence of B-Cell NHL during 2001-2010 13
Table 3: 6MM, Sources of B-Cell NHL Incidence Data 17
Table 4: 6MM, Incident Cases of Follicular Lymphoma, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 25
Table 5: 6MM, Age-Specific Incident Cases of Follicular Lymphoma, Both Sexes, N (Row %), 2013 27
Table 6: 6MM, Sex-Specific Incident Cases of Follicular Lymphoma, Ages ≥30 Years, N (Row %), 2013 28
Table 7: 6MM, Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 31
Table 8: 6MM, Age-Specific Incident Cases of Marginal Zone Lymphoma, Both Sexes, N (Row %), 2013 32
Table 9: 6MM, Sex-Specific Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, N (Row %), 2013 34
Table 10: 6MM, Incident Cases of DLBCL, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 37
Table 11: 6MM, Age-Specific Incident Cases of DLBCL, Both Sexes, N (Row %), 2013 38
Table 12: 6MM, Sex-Specific Incident Cases of DLBCL, Ages ≥30 Years, N (Row %), 2013 40
Table 13: 6MM, Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 43
Table 14: 6MM, Age-Specific Incident Cases of Mantle Cell Lymphoma, Both Sexes, N (Row %), 2013 44
Table 15: 6MM, Sex-Specific Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, N (Row %), 2013 46

1.2 List of Figures
Figure 1: 6MM, Incident Cases of Follicular Lymphoma, Ages ≥30 Years, Both Sexes, N, 2013-2023 26
Figure 2: 6MM, Age-Specific Incident Cases of Follicular Lymphoma, Both Sexes, N, 2013 27
Figure 3: 6MM, Sex-Specific Incident Cases of Follicular Lymphoma, Ages ≥30 Years, N, 2013 29
Figure 4: 6MM, Age-Standardized Incidence of Follicular Lymphoma (Cases per 100,000 Population), Ages ≥30 Years, 2013 30
Figure 5: 6MM, Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, Both Sexes, N, 2013-2023 31
Figure 6: 6MM, Age-Specific Incident Cases of Marginal Zone Lymphoma, Both Sexes, N, 2013 33
Figure 7: 6MM, Sex-Specific Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, N, 2013 35
Figure 8: 6MM, Age-Standardized Incidence of Marginal Zone Lymphoma (Cases per 100,000 Population), Ages ≥30 Years, 2013 36
Figure 9: 6MM, Incident Cases of DLBCL, Ages ≥30 Years, Both Sexes, N, 2013-2023 37
Figure 10: 6MM, Age-Specific Incident Cases of DLBCL, Both Sexes, N, 2013 39
Figure 11: 6MM, Sex-Specific Incident Cases of DLBCL, Ages ≥30 Years, N, 2013 41
Figure 12: 6MM, Age-Standardized Incidence of DLBCL (Cases per 100,000 Population), Ages ≥30 Years, 2013 42
Figure 13: 6MM, Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, Both Sexes, N, 2013-2023 43
Figure 14: 6MM, Age-Specific Incident Cases of Mantle Cell Lymphoma, Both Sexes, N, 2013 45
Figure 15: 6MM, Sex-Specific Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, N, 2013 46
Figure 16: 6MM, Age-Standardized Incidence of Mantle Cell Lymphoma (Cases per 100,000 Population), Ages ≥30 Years, 2013 47

*** レポートのキーワード ***

非ホジキンスリンパ腫

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界のスマート水道メーター市場予測
    KEY FINDINGSGlobal Smart water metering market is anticipated to increase at an approximate CAGR of 7.13% over the forecast years of 2017-2025. The market is increasingly being influenced by factors such as the impact of growing population, need to monitor and control non-revenue water, evolving sus …
  • セーフティーローザ―の世界及び中国市場 2018年
    The 'Global and Chinese Safety Razor Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Safety Razor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Safety Razor manufacturers …
  • 世界及び中国のアセトアニリド市場2016
    The 'Global and Chinese Acetanilide Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Acetanilide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Acetanilide manufacturers and is …
  • 鍛鋼粉砕媒体の世界市場2016
    The Global Forged Steel Grinding Media Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Forged Steel Grinding Media industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and in …
  • 世界及び中国の窒化カルシウム市場2016
    The 'Global and Chinese Calcium Nitride Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Calcium Nitride industry with a focus on the Chinese market. The report provides key statistics on the market status of the Calcium Nitride manu …
  • トンソン製薬(DONGSUNG PHARMACEUTICAL CO.,LTD)企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • SK Gas Co. Ltd. (018670):企業財務及びSWOT分析(エネルギー業界)
    Summary SK Gas Co. Ltd. (SK Gas) is an oil and gas service provider. The company operates its business through three divisions, namely, China business, LPG business and Exploration and Production (E&P). It offers services such as waste and water treatment, green energy business. SK Gas undertakes th …
  • インドの心臓律動管理(CRM)装置市場見通し
    India Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "India Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the India Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within mar …
  • 水性ポリウレタン樹脂の世界市場
    Aqueous Polyurethane Resins Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United St …
  • 米国のタービン市場(規模、トレンド、予測~2018年)
    The industry data report Turbine Market in United States to 2018 - Market Size, Trends, and Forecasts offers the most up-to-date market data on the actual market situation, trends and future outlook for turbines in United States. This research includes historic market data from 2007 to 2013 and fore …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHCER061 )"非ホジキンスリンパ腫(Non-Hodgkin’s Lymphoma):疫学予測(~2023)" (英文:EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2023)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。